Drugs / Aspirine
Aspirine
also known as
Kacip Fatimah extract · Labeesity · Lessertia Frutescens · LHP588 · low-dose · Sutherlandia Frutescens
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00549523 | Apr 2008 → Jan 2012 | HIV infectious disease | University of Missouri-Columbia | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT06847321 | Feb 2025 → Jan 2029 expected | Alzheimer disease | Lighthouse Pharmaceuticals, Inc. | Recruiting | No outcome recorded |
| Phase 2 | NCT04557267 | Sep 2020 → May 2021 | obesity disorder | Indonesia University | Completed | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00152646 | Mar 2005 → Jan 2008 | peripheral arterial disease | University Hospital, Angers | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02594410 Background | Sep 2011 → Mar 2014 | hypertensive disorder | Lee's Pharmaceutical Limited | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aspirine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02594410 ↗ |
| Known as | Kacip Fatimah extract | “In Malaysia, this Kacip Fatimah extract has been used as a natural anti-obesity drug and dietary supplement for healthy weight loss and healthy body by the trade-name of...” NCT04557267 ↗ |
| Known as | Labeesity | “In Malaysia, this Kacip Fatimah extract has been used as a natural anti-obesity drug and dietary supplement for healthy weight loss and healthy body by the trade-name of...” NCT04557267 ↗ |
| Known as | Lessertia Frutescens | “A Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of Lessertia Frutescens (L.)Goldblatt and J.C. Manning (Syn. Sutherlandia Frutescens (L.)R....” NCT00549523 ↗ |
| Known as | LHP588 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06847321 ↗ |
| Known as | low-dose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04557267 ↗ |
| Known as | Sutherlandia Frutescens | “A Randomized, Double-blind, Placebo-Controlled Study of the Safety and Efficacy of Lessertia Frutescens (L.)Goldblatt and J.C. Manning (Syn. Sutherlandia Frutescens (L.)R....” NCT00549523 ↗ |
| Route | Oral | “LHP588 25 mg, LHP588 50 mg, or placebo, orally, once daily (QD) in a fasted state” NCT06847321 ↗ |